The safety and efficacy of a selective Janus kinase 1 inhibitor were recently tested in nearly 500 patients with active rheumatoid arthritis with an inadequate response to biologic disease-modifying...
In a new study, researchers aimed to compare outcomes associated with treatment targets geared towards achieving low disease activity vs remission in patients with early active rheumatoid arthritis.
In a new study, researchers aimed to compare outcomes associated with treatment targets geared towards achieving low disease activity vs remission in patients with early active rheumatoid arthritis.
In a recent study, researchers detail various predictors of flare in patients with rheumatoid arthritis with sustained low disease activity who taper their anti-tumor necrosis factor therapy.
In a recent study, researchers detail various predictors of flare in patients with rheumatoid arthritis with sustained low disease activity who taper their anti-tumor necrosis factor therapy.
In the MOBILITY trial and the EXTEND long-term extension study, researchers assessed the safety and efficacy of sarilumab for the treatment of adults with rheumatoid arthritis with inadequate response to...
In the MOBILITY trial and the EXTEND long-term extension study, researchers assessed the safety and efficacy of sarilumab for the treatment of adults with rheumatoid arthritis with inadequate response to...
Although RA disease activity has been shown to be associated with serious infections and cardiovascular disease events in previous studies, there is a lack of large-scale population-based analyses on the...
Although RA disease activity has been shown to be associated with serious infections and cardiovascular disease events in previous studies, there is a lack of large-scale population-based analyses on the...
